DefinePK hosts the largest index of Pakistani journals, research articles, news headlines, and videos. It also offers chapter-level book search.
Title: Crimean-Congo Hemorrhagic Fever (CCHF): Our Experience at a Tertiary Hospital
Authors: Zubair Waheed Khan, Gulzar Ali, AKhlaq Ahmed, Muhammad Tariq, Adeel Gardezi, Nauman Sarir Khan
Journal: Pakistan Armed Forces Medical Journal (PAFMJ)
Publisher: Army Medical College, Rawalpindi.
Country: Pakistan
Year: 2022
Volume: 72
Issue: Supplementary 2
Language: English
DOI: 10.51253/pafmj.v72iSUPPL-2.3339
Keywords: Reverse transcriptase polymerase chain reaction (RT-PCR)Crimean-congo hemorrhagic fever (CCHF)Ribavirin
Objective: To share our experience of managing Crimean-Congo Hemorrhagic Fever cases at tertiary care hospital.
Study Design: Hospital based case series.
Place and Duration of study: Medicine department Combined Military Hospital Peshawar, from 2017 to 2019.
Methodology: A total of 10RT-PCR positive cases of Crimean-Congo Hemorrhagic Fever were included in the study. Data were collected retrospectively from Stat office of the hospital. All cases which were PCR negative, having multiple co-morbid conditions and having alternative diagnoses were excluded from the study. Demographic, epidemiological, clinical and laboratory parameters were noted on a specially designed Proforma.
Results: All patients were males armed forces personnel employed in the tribal areas of KPK. All patients initially developed fever and generalized body pains. Among them 2 (20%) patients developed petechial rash and 1(10%) suffered from epistaxis, melena and hematuria. All (100%) of the patients’ lab data revealed leukopenia, thrombocytopenia, elevated ALT and LDH. Complete recovery was noted in all patients. 8 (80%) of the patients received ribavirin and platelet transfusion. All patients under study also received oral Vitamin C supplement. Average hospital stay was 14 days.
Conclusion: Crimean-Congo Hemorrhagic Fever is a fatal disease. People visiting to endemic areas are at particular risk such as soldiers. It is manifested by fever, petechial rash and thrombocytopenia. Treatment is supportive. The role of oral vitamin C supplements and ribavirin to hasten recovery needs further high-powerstudies andshould be given to all suspected and confirmed cases.
To share the experience of managing Crimean-Congo Hemorrhagic Fever (CCHF) cases at a tertiary care hospital.
Hospital-based case series conducted at the Medicine department of Combined Military Hospital Peshawar from 2017 to 2019. Ten RT-PCR positive CCHF cases were included retrospectively. Cases with negative PCR, multiple co-morbidities, or alternative diagnoses were excluded. Demographic, epidemiological, clinical, and laboratory parameters were collected. Data analysis was performed using SPSS-22.
graph TD;
A["Identify CCHF Cases"] --> B["Collect Retrospective Data"];
B --> C["Apply Inclusion/Exclusion Criteria"];
C -- Included --> D["Record Demographic, Clinical, Lab Data"];
D --> E["Analyze Data using SPSS-22"];
E --> F["Interpret Findings"];
F --> G["Formulate Conclusion"];
CCHF is an endemic zoonotic disease transmitted by ticks, posing a risk to individuals in endemic areas, particularly soldiers. The study observed typical CCHF symptoms like fever, body ache, and bleeding tendencies. Laboratory findings of leukopenia and thrombocytopenia were consistent with previous studies. While ribavirin and platelet transfusions were administered, the role of ribavirin in hastening recovery requires further investigation, as some patients recovered without it. Oral Vitamin C was used as a supportive measure for vascular endothelial protection.
All ten patients were male armed forces personnel employed in tribal areas of KPK. Initial symptoms included fever and generalized body pains in all patients. Two patients developed petechial rash, and one experienced epistaxis, melena, and hematuria. Laboratory findings showed leukopenia, thrombocytopenia, and elevated ALT and LDH in all patients. All patients recovered completely. 80% received ribavirin and platelet transfusion, and all received oral Vitamin C. Average hospital stay was 14 days.
Crimean-Congo Hemorrhagic Fever is a potentially fatal disease, with individuals visiting endemic areas, such as soldiers, being at particular risk. Key manifestations include fever, petechial rash, and thrombocytopenia. Treatment is primarily supportive. The potential benefits of oral Vitamin C supplements and ribavirin in accelerating recovery warrant further high-power studies and should be considered for suspected and confirmed cases.
* The study included 10 RT-PCR positive cases of CCHF. (Confirmed in Methodology and Results)
* All patients were males and armed forces personnel employed in tribal areas of KPK. (Confirmed in Results)
* 80% of the patients received ribavirin and platelet transfusion. (Confirmed in Results)
Loading PDF...
Loading Statistics...